Skin cancer screening in organ transplant centres in the United Kingdom: a national survey
Autor: | John A.G. Gibson, Thomas D. Dobbs, Andrea Cordaro, Sairan Whitaker, Iain S. Whitaker |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Skin Neoplasms medicine.medical_treatment Dermatology 030230 surgery Organ transplantation Immunocompromised Host 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine medicine Humans Mass Screening Early Detection of Cancer Skin cancer screening integumentary system business.industry Skin examination Cancer Immunosuppression Organ Transplantation medicine.disease United Kingdom Increased risk Skin surveillance Skin cancer business Immunosuppressive Agents |
Zdroj: | European Journal of Dermatology. 30:372-376 |
ISSN: | 1952-4013 1167-1122 |
Popis: | Background Organ transplant recipients (OTRs) have up to 500-fold increased risk of keratinocyte skin cancer (KSC). International guidelines recommend at least annual skin cancer screening for OTRs. Objectives To explore the current skin cancer surveillance practice in UK transplant centres across all solid organs and the barriers to surveillance. Materials and methods An online survey was sent to all 59 transplant centres in the UK specialising in kidney (n = 24), pancreas (n = 10), heart and/or lung (n = 13), liver (n = 8) and intestine (n = 4) transplants. Results Fifty-one (86%) transplant centres responded. Twenty-eight (55%) centres provided skin cancer surveillance post-transplantation, of which 18 (64%) had a non-skin cancer specialist providing screening. Only 21 (41%) units performed a full skin examination. Eight units (29%) screened at least bi-annually in the first five years post-transplantation. Of the 23 (45%) centres that did not provide skin cancer surveillance, limitations included: reliance on patient-reported lesions (48%), lack of skin surveillance training (30%), lack of funding (48%), not a requirement in all patients (17%) and time restraints in the clinic (30%). Conclusion In the UK, many transplant units do not provide skin surveillance. Collaboration between skin cancer and transplant specialists would improve surveillance rates and reduce morbidity and mortality. |
Databáze: | OpenAIRE |
Externí odkaz: |